ID29979A - Turunan asam malonat baru, proses pembuatannya, penggunaannya dan komposisi sediaan farmasi yang mengandung bahan tersebut (penghambatan aktivitas faktor xa) - Google Patents
Turunan asam malonat baru, proses pembuatannya, penggunaannya dan komposisi sediaan farmasi yang mengandung bahan tersebut (penghambatan aktivitas faktor xa)Info
- Publication number
- ID29979A ID29979A IDW00200101430A ID20011430A ID29979A ID 29979 A ID29979 A ID 29979A ID W00200101430 A IDW00200101430 A ID W00200101430A ID 20011430 A ID20011430 A ID 20011430A ID 29979 A ID29979 A ID 29979A
- Authority
- ID
- Indonesia
- Prior art keywords
- declaration
- observation
- factor
- activity
- contain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99100002A EP1016663A1 (fr) | 1999-01-02 | 1999-01-02 | Dérivés de l'acide malonique, procédé pour leur préparation, leur utilisation comme médicaments et compositions les contenant (inhibiteurs du facteur Xa ) |
EP99119537 | 1999-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29979A true ID29979A (id) | 2001-10-25 |
Family
ID=26152843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101430A ID29979A (id) | 1999-01-02 | 1999-12-23 | Turunan asam malonat baru, proses pembuatannya, penggunaannya dan komposisi sediaan farmasi yang mengandung bahan tersebut (penghambatan aktivitas faktor xa) |
Country Status (17)
Country | Link |
---|---|
US (1) | US6395737B1 (fr) |
EP (1) | EP1140878A1 (fr) |
JP (1) | JP2002534420A (fr) |
KR (1) | KR20010101355A (fr) |
CN (1) | CN1332734A (fr) |
AU (1) | AU3043100A (fr) |
BR (1) | BR9916732A (fr) |
CA (1) | CA2358578A1 (fr) |
CZ (1) | CZ20012379A3 (fr) |
HK (1) | HK1041700A1 (fr) |
HU (1) | HUP0105437A3 (fr) |
ID (1) | ID29979A (fr) |
IL (1) | IL144096A0 (fr) |
NO (1) | NO20012983D0 (fr) |
PL (1) | PL349343A1 (fr) |
TR (1) | TR200101903T2 (fr) |
WO (1) | WO2000040571A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239478T3 (es) | 1999-01-02 | 2005-09-16 | Aventis Pharma Deutschland Gmbh | Derivados de arilalcanoilo, procedimientos para su preparacion, su uso y composiciones farmaceuticas que los contienen. |
EP1127884A1 (fr) * | 2000-02-26 | 2001-08-29 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédés pour leur préparation, leur utilisation comme inhibiteur du facteur XA et compositions les contenants |
FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
US9279022B1 (en) | 2014-09-08 | 2016-03-08 | Sirrus, Inc. | Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions |
US9249265B1 (en) | 2014-09-08 | 2016-02-02 | Sirrus, Inc. | Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions |
SG189933A1 (en) | 2010-10-20 | 2013-06-28 | Bioformix Llc | Synthesis of methylene malonates substantially free of impurities |
US9828324B2 (en) | 2010-10-20 | 2017-11-28 | Sirrus, Inc. | Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom |
US10414839B2 (en) | 2010-10-20 | 2019-09-17 | Sirrus, Inc. | Polymers including a methylene beta-ketoester and products formed therefrom |
EP2899183B1 (fr) | 2011-10-14 | 2018-09-19 | Bristol-Myers Squibb Company | Composés de tétrahydroisiquinoline substitués en tant qu'inhibiteurs du facteur Xia |
ES2625256T3 (es) | 2011-10-14 | 2017-07-19 | Bristol-Myers Squibb Company | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIA |
JP6033318B2 (ja) | 2011-10-14 | 2016-11-30 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 第XIa因子阻害剤としての置換テトラヒドロイソキノリン化合物 |
US9221739B2 (en) | 2011-10-19 | 2015-12-29 | Sirrus, Inc. | Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom |
CA2869108A1 (fr) | 2012-03-30 | 2013-10-03 | Bioformix Inc. | Procedes d'activation de compositions polymerisables, systemes polymerisables, et produits formes |
US10913875B2 (en) | 2012-03-30 | 2021-02-09 | Sirrus, Inc. | Composite and laminate articles and polymerizable systems for producing the same |
WO2013149173A1 (fr) | 2012-03-30 | 2013-10-03 | Bioformix Inc. | Formulations d'encre et de revêtement et systèmes polymérisables pour la production desdites formulations |
WO2013181600A2 (fr) | 2012-06-01 | 2013-12-05 | Bioformix Inc. | Matériau optique et objets formés à partir de celui-ci |
US9403774B2 (en) | 2012-10-12 | 2016-08-02 | Bristol-Myers Squibb Company | Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
WO2014059202A1 (fr) | 2012-10-12 | 2014-04-17 | Bristol-Myers Squibb Company | Composés de tétrahydroisoquinoléine substitués par guanidine comme inhibiteurs du facteur xia |
WO2014059203A1 (fr) | 2012-10-12 | 2014-04-17 | Bristol-Myers Squibb Company | Formes cristallines d'un inhibiteur de facteur xia |
WO2014078689A1 (fr) | 2012-11-16 | 2014-05-22 | Bioformix Inc. | Systèmes et procédés de liaison de matières plastiques |
EP2926368B1 (fr) | 2012-11-30 | 2020-04-08 | Sirrus, Inc. | Ensemble électronique |
CN110204441A (zh) | 2013-01-11 | 2019-09-06 | 瑟拉斯公司 | 经过双(羟甲基)丙二酸酯的途径获得亚甲基丙二酸酯的方法 |
EP2978751B1 (fr) | 2013-03-25 | 2018-12-05 | Bristol-Myers Squibb Company | Tétrahydroisoquinolines comprenant des azoles substitués en tant qu'inhibiteurs du facteur xia |
NO2760821T3 (fr) | 2014-01-31 | 2018-03-10 | ||
SG11201606209PA (en) | 2014-01-31 | 2016-08-30 | Bristol Myers Squibb Co | Macrocycles with hetrocyclic p2' groups as factor xia inhibitors |
CA2952968A1 (fr) | 2014-07-01 | 2016-01-07 | Rempex Pharmaceuticals, Inc. | Derives d'acide boronique et leurs utilisations therapeutiques |
JP6526796B2 (ja) | 2014-09-04 | 2019-06-05 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Fxia阻害剤であるジアミドマクロ環 |
US9315597B2 (en) | 2014-09-08 | 2016-04-19 | Sirrus, Inc. | Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures |
US9416091B1 (en) | 2015-02-04 | 2016-08-16 | Sirrus, Inc. | Catalytic transesterification of ester compounds with groups reactive under transesterification conditions |
US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
US10501400B2 (en) | 2015-02-04 | 2019-12-10 | Sirrus, Inc. | Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions |
US9334430B1 (en) | 2015-05-29 | 2016-05-10 | Sirrus, Inc. | Encapsulated polymerization initiators, polymerization systems and methods using the same |
US9217098B1 (en) | 2015-06-01 | 2015-12-22 | Sirrus, Inc. | Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound |
US9518001B1 (en) | 2016-05-13 | 2016-12-13 | Sirrus, Inc. | High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation |
US10428177B2 (en) | 2016-06-03 | 2019-10-01 | Sirrus, Inc. | Water absorbing or water soluble polymers, intermediate compounds, and methods thereof |
US9567475B1 (en) | 2016-06-03 | 2017-02-14 | Sirrus, Inc. | Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes |
US9617377B1 (en) | 2016-06-03 | 2017-04-11 | Sirrus, Inc. | Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes |
US10196481B2 (en) | 2016-06-03 | 2019-02-05 | Sirrus, Inc. | Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE235866C (fr) | ||||
DE242404C (fr) | ||||
DK425382A (da) * | 1981-09-25 | 1983-03-26 | Wellcome Found | Fremgangsmaade til fremstilling af amider |
CA2073776A1 (fr) | 1990-11-15 | 1992-05-16 | Joerg Stuerzebecher | Derives meta-substitues de la phenylalanine |
IT1254883B (it) * | 1992-04-16 | 1995-10-11 | Italfarmaco Spa | Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva. |
WO1994018185A1 (fr) * | 1993-02-10 | 1994-08-18 | Pentapharm Ag | Piperazides de derives substitues de phenylalanine utilises comme inhibiteurs de la thrombine |
US5977074A (en) * | 1993-10-01 | 1999-11-02 | Merrell Pharmaceuticals, Inc. | Inhibitors of β-amyloid protein production |
ES2214500T3 (es) * | 1994-04-26 | 2004-09-16 | Aventis Pharmaceuticals, Inc. | Inhibidores de factor xa. |
AU3107795A (en) * | 1994-08-09 | 1996-03-07 | Pentapharm Ag | Inhibitors of the benzamidine type |
GB9420763D0 (en) * | 1994-10-14 | 1994-11-30 | Glaxo Inc | Acetamide derivatives |
UA48993C2 (uk) * | 1995-12-20 | 2002-09-16 | Авентіс Фармасьютікалз, Інк | СПОСІБ ОТРИМАННЯ N-АЦЕТИЛ-(L)-4-ЦІАНОФЕНІЛАЛАНІНУ Аc-(L)-Phe(4-CN)-OH І N-АЦЕТИЛ-(L)-П-АМІДИНФЕНІЛАЛАНІН-ЦИКЛОГЕКСИЛГЛІЦИН-<font face="Symbol">b</font>-(3-N-МЕТИЛПІРИДИН)-АЛАНІНУ Аc-(L)-pАph-Сhg-PalMe(3)-NH<sub>2</sub> |
AU729910B2 (en) | 1997-05-02 | 2001-02-15 | Akzo Nobel N.V. | Serine protease inhibitors |
ES2241194T3 (es) | 1997-12-24 | 2005-10-16 | Aventis Pharma Deutschland Gmbh | Derivados de indol en calidad de inhibidores de factor xa. |
EP1016663A1 (fr) | 1999-01-02 | 2000-07-05 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédé pour leur préparation, leur utilisation comme médicaments et compositions les contenant (inhibiteurs du facteur Xa ) |
-
1999
- 1999-12-23 EP EP99964667A patent/EP1140878A1/fr not_active Withdrawn
- 1999-12-23 WO PCT/EP1999/010340 patent/WO2000040571A1/fr not_active Application Discontinuation
- 1999-12-23 IL IL14409699A patent/IL144096A0/xx unknown
- 1999-12-23 HU HU0105437A patent/HUP0105437A3/hu unknown
- 1999-12-23 AU AU30431/00A patent/AU3043100A/en not_active Abandoned
- 1999-12-23 BR BR9916732-8A patent/BR9916732A/pt not_active IP Right Cessation
- 1999-12-23 ID IDW00200101430A patent/ID29979A/id unknown
- 1999-12-23 CA CA002358578A patent/CA2358578A1/fr not_active Abandoned
- 1999-12-23 KR KR1020017008429A patent/KR20010101355A/ko not_active Application Discontinuation
- 1999-12-23 TR TR2001/01903T patent/TR200101903T2/xx unknown
- 1999-12-23 CN CN99815372A patent/CN1332734A/zh active Pending
- 1999-12-23 PL PL99349343A patent/PL349343A1/xx not_active Application Discontinuation
- 1999-12-23 JP JP2000592279A patent/JP2002534420A/ja not_active Abandoned
- 1999-12-23 CZ CZ20012379A patent/CZ20012379A3/cs unknown
- 1999-12-28 US US09/473,053 patent/US6395737B1/en not_active Expired - Lifetime
-
2001
- 2001-06-15 NO NO20012983A patent/NO20012983D0/no not_active Application Discontinuation
-
2002
- 2002-05-04 HK HK02103402.4A patent/HK1041700A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0105437A2 (hu) | 2002-05-29 |
KR20010101355A (ko) | 2001-11-14 |
NO20012983L (no) | 2001-06-15 |
JP2002534420A (ja) | 2002-10-15 |
BR9916732A (pt) | 2001-09-25 |
CA2358578A1 (fr) | 2000-07-13 |
PL349343A1 (en) | 2002-07-15 |
WO2000040571A1 (fr) | 2000-07-13 |
TR200101903T2 (tr) | 2001-11-21 |
NO20012983D0 (no) | 2001-06-15 |
CZ20012379A3 (cs) | 2001-09-12 |
US6395737B1 (en) | 2002-05-28 |
IL144096A0 (en) | 2002-05-23 |
EP1140878A1 (fr) | 2001-10-10 |
AU3043100A (en) | 2000-07-24 |
CN1332734A (zh) | 2002-01-23 |
HK1041700A1 (zh) | 2002-07-19 |
HUP0105437A3 (en) | 2003-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID29979A (id) | Turunan asam malonat baru, proses pembuatannya, penggunaannya dan komposisi sediaan farmasi yang mengandung bahan tersebut (penghambatan aktivitas faktor xa) | |
ID24730A (id) | Senyawa-senyawa heterosiklik untuk penghambatan sekresi asam lambung, proses pembuatan dan komposisi-komposisi farmasinya | |
ID26399A (id) | Turunan 1-(1-tersubstitusi-4-piperidinil) metil -4-piperidin, proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan intermedietnya | |
ID26395A (id) | Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya | |
ID18066A (id) | Fenil yang tersubstitusi guanidida guanidida asam alkenilkarboksilat proses pembuatannya dan penggunaannya sebagai obat atau diagnosa | |
DE60113121T2 (de) | Herstellung von vernetzter Hyaluronsäure und dessen Hydrogel, daraus hergestellte Produkte und deren Verwendung | |
TR200000289T2 (tr) | Kimyasal bileşimler | |
DE60116272D1 (de) | Malonsäure derivate, verfahren zu ihrer herstellung, ihre verwendung als inhibitor der faktor xa aktivität und pharmazeutische zusammensetzungen diese enthaltend | |
ID26207A (id) | ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI | |
HUP0104867A3 (en) | Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
DE69921941D1 (de) | Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln | |
IL130762A (en) | Quinoline and quinazoline compounds, pharmaceutical compositions comprising them, process for their preparation and use thereof in the manufacture of medicaments for the treatment of benign prostatic hyperplasia | |
NO20006630L (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
ATE204754T1 (de) | Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie | |
ID29256A (id) | Katalis oksida kompleksdan proses pembuatan asam akrilat | |
AR021347A1 (es) | Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma | |
ID20137A (id) | Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya | |
DE69842133D1 (de) | Zusammensetzungen und Kits zur Erhöhung der Abgabe von therapeutischen Mitteln an Zellen | |
ID22911A (id) | Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya | |
ID16501A (id) | Bentuk baru turunan asam alpha hidroksi pembuatan dan kegunaannya | |
ID17076A (id) | Turunan 2,4-disubstitusi pirimidin, proses untuk pembuatan zat yang sama dan komposisi farmasi yang mengandung zat yang sama | |
ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
ID21209A (id) | Turunan benzopiran tersubstitusi-sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung senyawa tersebut | |
DE60001255T2 (de) | Zusammensetzung zur Behandlung von Polyesterfaser | |
HUP0102847A2 (hu) | N-heterociklusos karbonsavak és izoszter karbonsavak karbamidjai és karbamátjai, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények |